Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center



  • Subscribe to our e-Newsletter to receive email updates:

  • Related Articles

    Most Recent


    Join Us

    News: Home Page Latest News

    Barocas named to Commission on Cancer

    Thursday, March 12th, 2015

    Daniel Barocas, M.D., MPH, assistant professor of Urologic Surgery at Vanderbilt University Medical Center, was recently named a representative on the Commission on Cancer. The program helps to raise the quality of care at hospitals across the country through developing standards for cancer care and uses those standards to accredit hospitals. Barocas will represent the […]

    Grant boosts head and neck lymphedema research

    Monday, March 9th, 2015

    Vanderbilt University School of Nursing (VUSN) has been awarded a four-year, $2.4 million grant from the National Institutes of Health/National Institute of Dental and Craniofacial Research to establish a valid, clinically useful measurement battery for head and neck lymphedema and fibrosis (LEF). Principal investigator Jie Deng, Ph.D., R.N., developed the proposal because she commonly sees […]

    MDS patient and family forum March 14

    Monday, March 2nd, 2015

    The Myelodysplastic Syndrome Foundation, Inc., is sponsoring a patient and caregiver forum on March 14, 2015 at the Marriott Nashville at Vanderbilt. The forum will feature a presentation and Q&A session with Vanderbilt-Ingram Cancer Center’s Michael Savona, M.D., about new therapies and treatment options for MDS. The conference runs from 9:30 a.m. to 2:00 p.m. and will also […]

    ‘Stretched’ cells promote cancer

    Thursday, February 26th, 2015

    Interactions between tumor cells and other cell types in the surrounding microenvironment (stroma) are crucial for tumor cell growth, survival and metastatic spread. Although tumor cells are known to induce mechanical changes in their microenvironment, few studies have examined the effect of mechanical stimuli on stromal cells such as fibroblasts. Donna Webb, Ph.D., Deyu Li, […]

    Gene profile predicts metastasis

    Thursday, February 12th, 2015

    Gene expression profiling has been applied to predict metastatic recurrence, the leading cause of deaths in patients with colorectal carcinoma. However, the biological mechanism is not completely understood, driving poor clinical outcomes. To address this issue, Dan Beauchamp, M.D., Bing Zhang, Ph.D., and colleagues analyzed the 11 human microarray datasets from 1,295 tumor specimens as […]

    Grant bolsters pancreatic cancer drug discovery

    Thursday, January 29th, 2015

    The Lustgarten Foundation has awarded a $1.5 million Research Investigator Grant to Stephen Fesik, Ph.D., professor of Biochemistry, Pharmacology and Chemistry, for research designed to discover new drugs for the treatment of pancreatic cancer. This is Fesik’s second three-year award from the Lustgarten Foundation in support of his research targeting K-Ras, a protein mutated in […]

    Data mining reveals cancer-driving genes

    Thursday, January 22nd, 2015

    Prospecting for genes that might be implicated in cancer, a Vanderbilt University Medical Center research team has struck pay dirt. Zhongming Zhao, Ph.D., Peilin Jia, Ph.D., and colleagues use novel computational methods to sift through online repositories of molecular data gathered by cancer researchers worldwide. These results, and further analyses planned by the team, can […]

    Combo therapy may help fight melanoma

    Thursday, January 8th, 2015

    Two therapies already in clinical development as single agents may work in combination to treat many subtypes of melanoma, a recent study suggests.

    More breast cancer patients choose mastectomy

    Friday, November 21st, 2014

    Far more breast cancer patients are choosing to undergo mastectomy, including removal of both breasts, instead of choosing breast conservation surgery even when they have early stage disease that is confined to one breast, a Vanderbilt study shows.

    New Insights on Postpartum Breast Cancer

    Friday, October 31st, 2014

    A new study explaining the cellular activity that leads to breast tumor metastasis among women who have recently given birth may offer new treatment direction for postpartum breast cancer.

    Next Page »« Previous Page


  • Subscribe to our e-Newsletter to receive email updates:

  • Related Articles

    Most Recent


    Join Us